These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25285572)

  • 1. The effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception.
    Atrio J; Stek A; Vora H; Sanchez-Keeland L; Zannat F; Natavio M
    Eur J Contracept Reprod Health Care; 2015 Apr; 20(2):149-53. PubMed ID: 25285572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of protease inhibitors on steady-state pharmacokinetics of oral norethindrone contraception in HIV-infected women.
    Atrio J; Stanczyk FZ; Neely M; Cherala G; Kovacs A; Mishell DR
    J Acquir Immune Defic Syndr; 2014 Jan; 65(1):72-7. PubMed ID: 24025339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy.
    DuBois BN; Atrio J; Stanczyk FZ; Cherala G
    Contraception; 2015 Jan; 91(1):71-5. PubMed ID: 25245190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing cervical mucus changes in response to an oral progestin or oestrogen withdrawal in ovarian-suppressed women: a clinical pilot.
    Han L; Padua E; Hart KD; Edelman A; Jensen JT
    Eur J Contracept Reprod Health Care; 2019 Jun; 24(3):209-215. PubMed ID: 31066303
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG; Steffens D; Schramm G
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones.
    Franklin RD; Kutteh WH
    J Reprod Immunol; 1999 Mar; 42(2):93-106. PubMed ID: 10221733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cervical mucus of 24/4 vs. 21/7 combined oral contraceptives.
    Steward R; Melamed A; Granat A; Mishell DR
    Contraception; 2012 Dec; 86(6):710-5. PubMed ID: 22682723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
    Joshi UM; Joshi JV; Donde UM; Sankoli GM; Virkar KD; Saxena BN
    Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical mucorrhea and spinnbarkeit in patients taking norethindrone plus mestranol (Norinyl 1-mg.).
    Cohen MR
    Fertil Steril; 1968; 19(3):405-10. PubMed ID: 4869631
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D; Smith S; Zacur H
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.
    Masson S; Franssen E; Hilditch JR; Powell MG
    Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of daily norethisterone (0.35 mg) on cervical mucus and on urinary LH, pregnanediol and oestrogen levels.
    Elstein M; Briston PG; Hewitt KJ; Kirk D; Miller H
    Br J Obstet Gynaecol; 1976 Feb; 83(2):165-8. PubMed ID: 1032819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of norethisterone oenanthate-a long acting injectable contraceptive on cervical mucus changes in adult female virgin rats.
    Akhter N; Choudhury SA
    Bangladesh Med Res Counc Bull; 1981 Dec; 7(2):52-8. PubMed ID: 7347605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants.
    Raymond EG; Singh M; Archer DF; Saxena BB; Baker J; Cole D
    Fertil Steril; 1996 Dec; 66(6):954-61. PubMed ID: 8941061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months.
    Spellacy WN; Ellingson AB; Kotlik A; Tsibris JC
    Am J Obstet Gynecol; 1988 Oct; 159(4):877-9. PubMed ID: 3052079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The progestogen-only mini-pill.
    Graham S; Fraser IS
    Contraception; 1982 Oct; 26(4):373-88. PubMed ID: 6759029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal relationship between Uniplant insertion and changes in cervical mucus.
    Barbosa IC; Coutinho E; Hirsch C; Ladipo OA; Olsson SE; Ulmsten U
    Contraception; 1996 Oct; 54(4):213-7. PubMed ID: 8922874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives.
    Fels H; Steward R; Melamed A; Granat A; Stanczyk FZ; Mishell DR
    Contraception; 2013 Jun; 87(6):732-7. PubMed ID: 23352800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE; Doose DR; Walker SA; Nayak RK
    Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.